2021-11-16-世界卫生组织-Cervical_cancer_Trinidad_and_Tobago_2021_country_profile_1页_65kb

Cervical Cancer Profile: Trinidad and Tobago

• Morbidity and Mortality:

  • Crude cervical cancer incidence in 2020 was 28.5 per 100,000 women.
  • Mortality in 2019 was 3,900 deaths among 706,000 females.
  • Mortality-to-incidence ratio in 2020 was 0.63.
  • Age-standardized incidence and cumulative risk vary, but data indicates the burden exists.

• Primary Prevention:

  • HPV vaccination is part of the national program, introduced in 2013 (targeting 11-15 years).
  • Coverage among 9-14-year-old girls: 53%, with the final dose less common (<10%).
  • National program coverage: 53% (data for all ages not specified).

• Secondary Prevention:

  • National screening program exists, using cytology.
  • Ever screened: 66% among women aged 18-65.
  • Last 5 years screening: 56%.
  • Targeted for ages 18-65, with defined early detection methods.

• Treatment and Supportive Care:

  • National guidelines exist for management.
  • Medical and radiation oncologists are present (2014, 2019 data).
  • Radiotherapy and chemotherapy services are available in tertiary centers.
  • Palliative care and opioid consumption data indicate accessibility, though specifics vary.

• WHO Elimination Strategy:

  • Targets aim for reduced incidence and deaths by 2030.
  • Data shows moderate progress in vaccination and screening.